TRANSMEDICAL : revenue, balance sheet and financial ratios

TRANSMEDICAL is a French company founded 21 years ago, specialized in the sector Services administratifs combinés de bureau. Based in MARSEILLE (13010), this company of category PME shows in 2022 a revenue of 1.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - TRANSMEDICAL (SIREN 479161739)
Indicator 2023 2022 2021 2020 2019 2018
Revenue N/C 1 009 857 € 1 020 249 € 1 013 737 € 950 225 € 839 431 €
Net income 57 696 € 8 741 € 128 € 50 403 € 136 372 € 64 072 €
EBITDA N/C 70 468 € 41 722 € 122 215 € 224 434 € 126 829 €
Net margin N/C 0.9% 0.0% 5.0% 14.4% 7.6%

Revenue and income statement

In 2023, TRANSMEDICAL generates positive net income of 58 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2023: 64 k€ -> 58 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

57 696 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 14%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

13.821%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

54.938%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

33.6%

Solvency indicators evolution
TRANSMEDICAL

Sector positioning

Debt ratio
13.82 2023
2021
2022
2023
Q1: 0.0
Med: 13.93
Q3: 108.64
Good

In 2023, the debt ratio of TRANSMEDICAL (13.82) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
54.94% 2023
2021
2022
2023
Q1: 6.13%
Med: 40.08%
Q3: 78.78%
Good +9 pts over 3 years

In 2023, the financial autonomy of TRANSMEDICAL (54.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.63 years 2022
2021
2022
Q1: 0.0 years
Med: 0.01 years
Q3: 3.18 years
Average

In 2022, the repayment capacity of TRANSMEDICAL (0.63) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 205.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

205.881

Liquidity indicators evolution
TRANSMEDICAL

Sector positioning

Liquidity ratio
205.88 2023
2021
2022
2023
Q1: 104.45
Med: 301.0
Q3: 1404.82
Average +9 pts over 3 years

In 2023, the liquidity ratio of TRANSMEDICAL (205.88) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
3.66x 2022
2021
2022
Q1: -14.33x
Med: 0.0x
Q3: 0.09x
Excellent

In 2022, the interest coverage of TRANSMEDICAL (3.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
TRANSMEDICAL

Positioning of TRANSMEDICAL in its sector

Comparison with sector Services administratifs combinés de bureau

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (27 transactions). This range of 70 447€ to 620 767€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2023
Indicative
70k€ 338k€ 620k€
338 534 € Range: 70 447€ - 620 767€
NAF 5 année 2023

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 27 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Services administratifs combinés de bureau)

Compare TRANSMEDICAL with other companies in the same sector:

Voir toutes les statistiques du secteur Services administratifs combinés de bureau

Frequently asked questions about TRANSMEDICAL

What is the revenue of TRANSMEDICAL ?

The revenue of TRANSMEDICAL in 2022 is 1.0 M€.

Is TRANSMEDICAL profitable?

Yes, TRANSMEDICAL generated a net profit of 58 k€ in 2023.

Where is the headquarters of TRANSMEDICAL ?

The headquarters of TRANSMEDICAL is located in MARSEILLE (13010), in the department Bouches-du-Rhone.

Where to find the tax return of TRANSMEDICAL ?

The tax return of TRANSMEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does TRANSMEDICAL operate?

TRANSMEDICAL operates in the sector Services administratifs combinés de bureau (NAF code 82.11Z). See the 'Sector positioning' section above to compare the company with its competitors.